CANNAPHARMARX, INC. Quarterly Interest Expense in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cannapharmarx, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2015 to Q3 2024.
  • Cannapharmarx, Inc. Interest Expense for the quarter ending September 30, 2024 was $632K, a 78% increase year-over-year.
  • Cannapharmarx, Inc. annual Interest Expense for 2022 was $2.29M, a 51.9% increase from 2021.
  • Cannapharmarx, Inc. annual Interest Expense for 2021 was $1.51M, a 34.3% decline from 2020.
  • Cannapharmarx, Inc. annual Interest Expense for 2020 was $2.29M, a 48.7% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $632K +$277K +78% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q1 2024 $576K +$117K +25.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-25
Q3 2023 $2.02M $355K -$86.8K -19.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $2.1M $355K -$195K -35.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-10-13
Q1 2023 $2.3M $459K +$8.2K +1.82% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-25
Q4 2022 $2.29M $847K +$639K +306% Oct 1, 2022 Dec 31, 2022 10-K 2023-09-01
Q3 2022 $1.65M $442K +$182K +69.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 $1.47M $550K -$59.5K -9.75% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-13
Q1 2022 $1.53M $451K +$22.3K +5.19% Jan 1, 2022 Mar 31, 2022 10-Q 2023-09-22
Q4 2021 $1.51M $209K -$366K -63.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-09-01
Q3 2021 $1.87M $260K -$98.8K -27.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $1.97M $610K -$31.5K -4.92% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 $2M $429K -$290K -40.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $2.29M $574K -$820K -58.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 $3.11M $359K -$2.54M -87.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $5.65M $641K +$582K +983% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $5.07M $719K +$598K +491% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $4.47M $1.39M +$169K +13.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-14
Q3 2019 $4.3M $2.9M +$1.98M +217% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.32M $59.2K +$59.2K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 $2.26M $122K +$122K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 $2.14M $1.23M +$1.23M Oct 1, 2018 Dec 31, 2018 10-K 2020-05-27
Q3 2018 $914K $914K +$914K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $0 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $0 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $0 $0 $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-04-03
Q3 2017 $0 $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $0 $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-09-14
Q1 2017 $0 $0 -$423K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-09-14
Q4 2016 $423K $0 -$653 -100% Oct 1, 2016 Dec 31, 2016 10-K 2018-09-14
Q3 2016 $424K $0 -$518 Jul 1, 2016 Sep 30, 2016 10-Q 2018-09-14
Q2 2016 $424K $0 -$776 -100% Apr 1, 2016 Jun 30, 2016 10-Q 2018-09-14
Q1 2016 $425K $423K +$422K +54340% Jan 1, 2016 Mar 31, 2016 10-Q 2018-09-14
Q4 2015 $2.72K $653 Oct 1, 2015 Dec 31, 2015 10-K 2018-09-14
Q3 2015 $518* Jul 1, 2015 Sep 30, 2015 10-Q 2018-09-14
Q2 2015 $776 Apr 1, 2015 Jun 30, 2015 10-Q 2018-09-14
Q1 2015 $777 Jan 1, 2015 Mar 31, 2015 10-Q 2018-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.